Research Article
BibTex RIS Cite

Depresyon ve Anksiyete Skorlarının Sigara Bırakma Tedavisi Üzerine Etkisi

Year 2018, Volume: 10 Issue: 2, 128 - 133, 15.08.2018
https://doi.org/10.18521/ktd.351519

Abstract

Amaç: Birçok psikiyatrik hastalıkta sigara içme prevalansı
yüksektir. Bu çalışmanın amacı depresyon ve anksiyete
skorlarının sigara bırakma tedavisi üzerine etkisini değerlendirmektir
.

Gereç
ve Yöntem:
2016 yılında Sağlık Bilimleri Üniversitesi
Konya Eğitim ve Araştırma Hastanesi Sigara Bırakma Polikliniğine başvuran
hastaların kayıtları retrospektif olarak değerlendirildi.
Toplam 560 hasta kaydı araştırıldı. Kayıtlar Beck Depresyon Ölçeği (BDS), Beck
Anksiyete Ölçeği (BAS), Fagerström Nikotin Bağımlılık Testi (FNDT),
karbonmonoksit (CO) ölçümü ve sosyodemografik anket formundan oluşmaktadır.
Hastalar, bırakma tedavisinin başlamasının ardından
3. ayda telefonla aranmış ve sigarayı bırakıp bırakmadıkları sorulmuştur. Bu
çalışmaya toplam 560 hasta ile başlanmasına rağmen, 3 ay sonra telefonla
ulaşılabilen 517 hasta ile çalışma tamamlandı
.

Bulgular: Sigarayı bırakanların yaş
ortalaması, bırakamayanlara göre daha yüksekti (p = 0.002). Aksine, sigarayı
bırakamayan hastalarda ortalama CO düzeyleri (p <0.001) ve ortalama BDS (p
<0.001) ve BAS (p <0.001) skorları anlamlı olarak yüksek bulundu.
Hastaların diğer temel özellikleri gruplar arasında
istatistiksel olarak farklı değildi
.







Sonuç: Yüksek depresyon ve anksiyete skorları sigara bırakma
tedavisinin başarı oranını azaltır. Bu hastaların anksiyete ve depresyon
açısından değerlendirilmeleri, sağlık profesyonellerinin
tıbbi tedavi ile birlikte psikososyal danışmanlık sağlaması ve gerektiğinde
psikiyatristle konsülte edilmesi, bu hastalarda yüksek başarı elde etmek için
önemli basamaklardır
.

References

  • REFERENCES
  • 1. Organization WH. Global status report on noncommunicable diseases 2014. 2014. Geneva, Switzerland: World Health Organization Google Scholar. 2015.
  • 2. Reichert J, Araujo AJ, Goncalves CM, Godoy I, Chatkin JM, Sales MP, et al. Smoking cessation guidelines-2008. J Bras Pneumol. 2008; 34 (10): 845-880.
  • 3. Solak ZA, Telli CG, Erdinç E. Sigarayı bırakma tedavisinin sonuçları. Toraks Dergisi. 2003; 4 (1): 73-77.
  • 4. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav. 2004; 29 (6): 1067-1083.
  • 5. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001; 357 (9272): 1929-1932.
  • 6. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, et al. Smoking, smoking cessation, and major depression. JAMA. 1990; 264 (12): 1546-1549.
  • 7. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000; 284 (20): 2606-2610.
  • 8. Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA. The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population. Addiction. 2012; 107 (10): 1847-1856.
  • 9. McClave AK, Dube SR, Strine TW, Kroenke K, Caraballo RS, Mokdad AH. Associations between smoking cessation and anxiety and depression among U.S. adults. Addict Behav. 2009; 34 (6-7): 491-497.
  • 10. Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its assessment. Ear, nose, & throat journal. 1990; 69 (11): 763-765.
  • 11. Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. Bmj. 1994; 309 (6958): 842-846.
  • 12. Uzaslan E, Ozyardimci N, Karadag M, Yuksel E, Gozu R, Ege E. The physician's intervention in smoking cessation: Results of the five years of smoking cessation clinic. Annals of Medical Sciences. 2000; 9 (2): 63-69.
  • 13. Çan G, Öztuna F, Özlü T. The evaluation of our smoking cessation clinic results. Eur Respir J. 2002; 38 (579): P3584.
  • 14. Monso E, Campbell J, Tønnesen P, Gustavsson G, Morera J. Sociodemographic predictors of success in smoking intervention. Tobacco Control. 2001; 10 (2): 165-169.
  • 15. Raherison C, Marjary A, Valpromy B, Prevot S, Fossoux H, Taytard A. Evaluation of smoking cessation success in adults. Respiratory medicine. 2005; 99 (10): 1303-1310.
  • 16. Fidan F, Pala E, Ünlü M, Sezer M, Kara Z. Sigara bırakmayı etkileyen faktörler ve uygulanan tedavilerin başarı oranları. Kocatepe Tıp Dergisi. 2005; 6 (3): 17-22.
  • 17. Fernandez E, Garcia M, Schiaffino A, Borras JM, Nebot M, Segura A. Smoking initiation and cessation by gender and educational level in Catalonia, Spain. Preventive medicine. 2001; 32 (3): 218-223.
  • 18. Osler M, Prescott E. Psychosocial, behavioural, and health determinants of successful smoking cessation: a longitudinal study of Danish adults. Tobacco control. 1998; 7 (3): 262-267.
  • 19. Gorecka D, Bednarek M, Nowinski A, Puscinska E, Goljan-Geremek A, Zielinski J. Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. CHEST Journal. 2003; 123 (6): 1916-1923.
  • 20. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation: who will quit with and without the nicotine patch. Jama. 1994; 271 (8): 589-594.
  • 21. Şahbaz S, Kılınç O, Günay T, Ceylan E. Sigara içme ve demografik özelliklerin sigara bırakma tedavilerinin sonuçlarına etkileri. Toraks Dergisi. 2007; 8 (2): 110-114.
  • 22. Janson C, Künzli N, de Marco Ra, Chinn S, Jarvis D, Svanes C, et al. Changes in active and passive smoking in the European Community Respiratory Health Survey. European respiratory journal. 2006; 27 (3): 517-524.
  • 23. Argüder E, Karalezli A, Hezer H, Kılıç H, Er M, Hasanoğlu HC, et al. Sigara bırakma başarısını etkileyen faktörler. Tur Toraks Derg. 2013; 14: 81-87.
  • 24. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine. 1999; 340 (9): 685-691.
  • 25. Türkcan A, Çakmak D. Sigara bağımlılarında solunum havasında karbon monoksit düzeyleri. Bağımlılık Dergisi. 2004; 5 (3): 133-138.
  • 26. Yaşar Z, Kurt ÖK, Talay F, Kargı A. Bir yıllık sigara bırakma poliklinik sonuçlarımız: sigara bırakmada etkili olan faktörler. Eurasian J Pulmonol. 2014; 16: 99-104.
  • 27. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addictive behaviors. 2004; 29 (6): 1067-1083.
  • 28. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. The Lancet. 2001; 357 (9272): 1929-1932.
  • 29. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, et al. Smoking, smoking cessation, and major depression. Jama. 1990; 264 (12): 1546-1549.
  • 30. Van der Meer RM, Willemsen MC, Smit F, Cuijpers P. Smoking cessation interventions for smokers with current or past depression. The Cochrane database of systematic reviews. 2013 (8): CD006102.
  • 31. Weinberger AH, Kashan RS, Shpigel DM, Esan H, Taha F, Lee CJ, et al. Depression and cigarette smoking behavior: a critical review of population-based studies. The American journal of drug and alcohol abuse. 2016: 1-16.

Effects of Depression and Anxiety Scores on Smoking Cessation Treatment

Year 2018, Volume: 10 Issue: 2, 128 - 133, 15.08.2018
https://doi.org/10.18521/ktd.351519

Abstract

Objective: Smoking prevalence is
high in many psychiatric diseases. The aim of this study is to evaluate
depression and anxiety effect among smoking cessation treatment
.

Methods: Records of patients who
admitted to the smoking cessation clinic in Health Sciences University, Konya
Education and Research Hospital, in 2016 were retrospectively evaluated. A
total of 560 patients’ records were investigated. Records consisted of Beck Depression Scale (BDS), Beck Anxiety Scale (BAS), Fagerström
Nicotine Dependence Test (FNDT), carbon-monoxide (CO) measurement, and
sociodemographic questionnaire form. Patients were called by phone at the 3rd
month following initiation of cessation treatment,
and asked whether they quit smoking or not. Although this study was started
with total 560 patients, the study was completed with 517 patients who could be
reached by telephone 3 months later
.

Results: The mean age of
quitters was higher than the ones who could not
(p=0.002). Contrary, the mean CO levels (p<0.001), and the mean BDS
(p<0.001) and BAS (p<0.001) scores were significantly higher in patients
who failed to quit. Remaining characteristics of the patients were not
statistically different between groups
.

Conclusions: High depression and
anxiety scores decreases the success rates of smoking cessation treatments.
Assessment of these patients regarding anxiety and depression, providing
psychosocial counselling by health professionals
together with the medical treatment, and consulting with a psychiatrist when
needed are important steps for achieving high quit success in these patients
.


References

  • REFERENCES
  • 1. Organization WH. Global status report on noncommunicable diseases 2014. 2014. Geneva, Switzerland: World Health Organization Google Scholar. 2015.
  • 2. Reichert J, Araujo AJ, Goncalves CM, Godoy I, Chatkin JM, Sales MP, et al. Smoking cessation guidelines-2008. J Bras Pneumol. 2008; 34 (10): 845-880.
  • 3. Solak ZA, Telli CG, Erdinç E. Sigarayı bırakma tedavisinin sonuçları. Toraks Dergisi. 2003; 4 (1): 73-77.
  • 4. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav. 2004; 29 (6): 1067-1083.
  • 5. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001; 357 (9272): 1929-1932.
  • 6. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, et al. Smoking, smoking cessation, and major depression. JAMA. 1990; 264 (12): 1546-1549.
  • 7. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000; 284 (20): 2606-2610.
  • 8. Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA. The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: longitudinal evaluation in the US population. Addiction. 2012; 107 (10): 1847-1856.
  • 9. McClave AK, Dube SR, Strine TW, Kroenke K, Caraballo RS, Mokdad AH. Associations between smoking cessation and anxiety and depression among U.S. adults. Addict Behav. 2009; 34 (6-7): 491-497.
  • 10. Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and its assessment. Ear, nose, & throat journal. 1990; 69 (11): 763-765.
  • 11. Gourlay SG, Forbes A, Marriner T, Pethica D, McNeil JJ. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. Bmj. 1994; 309 (6958): 842-846.
  • 12. Uzaslan E, Ozyardimci N, Karadag M, Yuksel E, Gozu R, Ege E. The physician's intervention in smoking cessation: Results of the five years of smoking cessation clinic. Annals of Medical Sciences. 2000; 9 (2): 63-69.
  • 13. Çan G, Öztuna F, Özlü T. The evaluation of our smoking cessation clinic results. Eur Respir J. 2002; 38 (579): P3584.
  • 14. Monso E, Campbell J, Tønnesen P, Gustavsson G, Morera J. Sociodemographic predictors of success in smoking intervention. Tobacco Control. 2001; 10 (2): 165-169.
  • 15. Raherison C, Marjary A, Valpromy B, Prevot S, Fossoux H, Taytard A. Evaluation of smoking cessation success in adults. Respiratory medicine. 2005; 99 (10): 1303-1310.
  • 16. Fidan F, Pala E, Ünlü M, Sezer M, Kara Z. Sigara bırakmayı etkileyen faktörler ve uygulanan tedavilerin başarı oranları. Kocatepe Tıp Dergisi. 2005; 6 (3): 17-22.
  • 17. Fernandez E, Garcia M, Schiaffino A, Borras JM, Nebot M, Segura A. Smoking initiation and cessation by gender and educational level in Catalonia, Spain. Preventive medicine. 2001; 32 (3): 218-223.
  • 18. Osler M, Prescott E. Psychosocial, behavioural, and health determinants of successful smoking cessation: a longitudinal study of Danish adults. Tobacco control. 1998; 7 (3): 262-267.
  • 19. Gorecka D, Bednarek M, Nowinski A, Puscinska E, Goljan-Geremek A, Zielinski J. Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. CHEST Journal. 2003; 123 (6): 1916-1923.
  • 20. Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation: who will quit with and without the nicotine patch. Jama. 1994; 271 (8): 589-594.
  • 21. Şahbaz S, Kılınç O, Günay T, Ceylan E. Sigara içme ve demografik özelliklerin sigara bırakma tedavilerinin sonuçlarına etkileri. Toraks Dergisi. 2007; 8 (2): 110-114.
  • 22. Janson C, Künzli N, de Marco Ra, Chinn S, Jarvis D, Svanes C, et al. Changes in active and passive smoking in the European Community Respiratory Health Survey. European respiratory journal. 2006; 27 (3): 517-524.
  • 23. Argüder E, Karalezli A, Hezer H, Kılıç H, Er M, Hasanoğlu HC, et al. Sigara bırakma başarısını etkileyen faktörler. Tur Toraks Derg. 2013; 14: 81-87.
  • 24. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine. 1999; 340 (9): 685-691.
  • 25. Türkcan A, Çakmak D. Sigara bağımlılarında solunum havasında karbon monoksit düzeyleri. Bağımlılık Dergisi. 2004; 5 (3): 133-138.
  • 26. Yaşar Z, Kurt ÖK, Talay F, Kargı A. Bir yıllık sigara bırakma poliklinik sonuçlarımız: sigara bırakmada etkili olan faktörler. Eurasian J Pulmonol. 2014; 16: 99-104.
  • 27. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addictive behaviors. 2004; 29 (6): 1067-1083.
  • 28. Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. The Lancet. 2001; 357 (9272): 1929-1932.
  • 29. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, et al. Smoking, smoking cessation, and major depression. Jama. 1990; 264 (12): 1546-1549.
  • 30. Van der Meer RM, Willemsen MC, Smit F, Cuijpers P. Smoking cessation interventions for smokers with current or past depression. The Cochrane database of systematic reviews. 2013 (8): CD006102.
  • 31. Weinberger AH, Kashan RS, Shpigel DM, Esan H, Taha F, Lee CJ, et al. Depression and cigarette smoking behavior: a critical review of population-based studies. The American journal of drug and alcohol abuse. 2016: 1-16.
There are 32 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Articles
Authors

İbrahim Solak

Duygu İlke Yıldırım

Fatma Gümüş This is me

İbrahim Eren

Mehmet Ali Eryılmaz This is me

Publication Date August 15, 2018
Acceptance Date May 18, 2018
Published in Issue Year 2018 Volume: 10 Issue: 2

Cite

APA Solak, İ., Yıldırım, D. İ., Gümüş, F., Eren, İ., et al. (2018). Effects of Depression and Anxiety Scores on Smoking Cessation Treatment. Konuralp Medical Journal, 10(2), 128-133. https://doi.org/10.18521/ktd.351519
AMA Solak İ, Yıldırım Dİ, Gümüş F, Eren İ, Eryılmaz MA. Effects of Depression and Anxiety Scores on Smoking Cessation Treatment. Konuralp Medical Journal. August 2018;10(2):128-133. doi:10.18521/ktd.351519
Chicago Solak, İbrahim, Duygu İlke Yıldırım, Fatma Gümüş, İbrahim Eren, and Mehmet Ali Eryılmaz. “Effects of Depression and Anxiety Scores on Smoking Cessation Treatment”. Konuralp Medical Journal 10, no. 2 (August 2018): 128-33. https://doi.org/10.18521/ktd.351519.
EndNote Solak İ, Yıldırım Dİ, Gümüş F, Eren İ, Eryılmaz MA (August 1, 2018) Effects of Depression and Anxiety Scores on Smoking Cessation Treatment. Konuralp Medical Journal 10 2 128–133.
IEEE İ. Solak, D. İ. Yıldırım, F. Gümüş, İ. Eren, and M. A. Eryılmaz, “Effects of Depression and Anxiety Scores on Smoking Cessation Treatment”, Konuralp Medical Journal, vol. 10, no. 2, pp. 128–133, 2018, doi: 10.18521/ktd.351519.
ISNAD Solak, İbrahim et al. “Effects of Depression and Anxiety Scores on Smoking Cessation Treatment”. Konuralp Medical Journal 10/2 (August 2018), 128-133. https://doi.org/10.18521/ktd.351519.
JAMA Solak İ, Yıldırım Dİ, Gümüş F, Eren İ, Eryılmaz MA. Effects of Depression and Anxiety Scores on Smoking Cessation Treatment. Konuralp Medical Journal. 2018;10:128–133.
MLA Solak, İbrahim et al. “Effects of Depression and Anxiety Scores on Smoking Cessation Treatment”. Konuralp Medical Journal, vol. 10, no. 2, 2018, pp. 128-33, doi:10.18521/ktd.351519.
Vancouver Solak İ, Yıldırım Dİ, Gümüş F, Eren İ, Eryılmaz MA. Effects of Depression and Anxiety Scores on Smoking Cessation Treatment. Konuralp Medical Journal. 2018;10(2):128-33.